SRDX
Income statement / Annual
Last year (2024), Surmodics, Inc.'s total revenue was $126.08 M,
a decrease of 4.91% from the previous year.
In 2024, Surmodics, Inc.'s net income was -$11.54 M.
See Surmodics, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
09/30/2024 |
09/30/2023 |
09/30/2022 |
09/30/2021 |
09/30/2020 |
09/30/2019 |
09/30/2018 |
09/30/2017 |
09/30/2016 |
09/30/2015 |
| Operating Revenue |
$126.08 M
|
$132.58 M
|
$99.95 M
|
$105.14 M
|
$94.86 M
|
$100.08 M
|
$81.34 M
|
$73.11 M
|
$71.37 M
|
$61.90 M
|
| Cost of Revenue |
$33.03 M |
$71.56 M |
$70.95 M |
$63.91 M |
$65.51 M |
$66.52 M |
$54.97 M |
$43.24 M |
$29.41 M |
$24.78 M |
| Gross Profit |
$93.05 M |
$61.02 M |
$29.00 M |
$41.23 M |
$29.36 M |
$33.55 M |
$26.37 M |
$29.87 M |
$41.96 M |
$37.11 M |
| Gross Profit Ratio |
0.74 |
0.46 |
0.29 |
0.39 |
0.31 |
0.34 |
0.32 |
0.41 |
0.59 |
0.6 |
| Research and Development
Expenses |
$10.00 M
|
$9.57 M
|
$9.08 M
|
$46.73 M
|
$50.19 M
|
$52.89 M
|
$40.97 M
|
$31.82 M
|
$18.50 M
|
$16.17 M
|
| General & Administrative
Expenses |
$0.00
|
$0.00
|
$46.94 M
|
$30.68 M
|
$28.39 M
|
$23.95 M
|
$24.11 M
|
$20.48 M
|
$18.00 M
|
$18.03 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$12,000.00
|
$3,000.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$56.84 M
|
$51.88 M
|
$46.95 M
|
$30.68 M
|
$28.39 M
|
$23.95 M
|
$24.11 M
|
$20.48 M
|
$18.00 M
|
$18.03 M
|
| Other Expenses |
$31.86 M |
-$2.66 M |
-$4.93 M |
$2.79 M |
-$47.97 M |
-$50.48 M |
$1.27 M |
-$70,000.00 |
$89,000.00 |
$496,000.00 |
| Operating Expenses |
$98.70 M |
$55.42 M |
$51.10 M |
$33.47 M |
$30.61 M |
$26.36 M |
$26.60 M |
$22.90 M |
$20.42 M |
$18.03 M |
| Cost And Expenses |
$131.72 M |
$126.98 M |
$122.05 M |
$97.38 M |
$96.12 M |
$92.88 M |
$81.57 M |
$66.14 M |
$49.83 M |
$42.81 M |
| Interest Income |
$0.00 |
$1.08 M |
$99,000.00 |
$123,000.00 |
$656,000.00 |
$1.10 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$0.00 |
-$3.49 M |
$598,000.00 |
$310,000.00 |
$133,000.00 |
$152,000.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$8.69 M
|
$9.17 M
|
$9.67 M
|
$8.32 M
|
$7.51 M
|
$7.31 M
|
$6.43 M
|
$5.56 M
|
$4.87 M
|
$2.81 M
|
| EBITDA |
-$5.65 M
|
$14.58 M
|
-$12.96 M
|
$11.59 M
|
$967,000.00
|
$10.33 M
|
$10.82 M
|
$9.27 M
|
$28.64 M
|
$21.74 M
|
| EBITDA Ratio |
-0.04 |
0.11 |
-0.13 |
0.11 |
0.01 |
0.1 |
0.13 |
0.13 |
0.4 |
0.35 |
| Operating Income Ratio
|
-0.04
|
0.04
|
-0.22
|
0.06
|
-0.01
|
0.06
|
-0.11
|
0.1
|
0.24
|
0.31
|
| Total Other
Income/Expenses Net |
-$1.86 M
|
-$3.12 M
|
-$396,000.00
|
-$357,000.00
|
-$203,000.00
|
$1.09 M
|
-$7.30 M
|
$57,000.00
|
-$4.59 M
|
$652,000.00
|
| Income Before Tax |
-$7.51 M |
$2.49 M |
-$22.49 M |
$6.35 M |
-$1.45 M |
$7.56 M |
-$7.53 M |
$7.03 M |
$16.95 M |
$19.74 M |
| Income Before Tax Ratio
|
-0.06
|
0.02
|
-0.23
|
0.06
|
-0.02
|
0.08
|
-0.09
|
0.1
|
0.24
|
0.32
|
| Income Tax Expense |
-$4.04 M |
$4.02 M |
$4.78 M |
$2.11 M |
-$2.58 M |
-$34,000.00 |
-$3.08 M |
$3.11 M |
$6.96 M |
$6.29 M |
| Net Income |
-$11.54 M |
-$1.54 M |
-$27.27 M |
$4.24 M |
$1.12 M |
$7.59 M |
-$4.46 M |
$3.93 M |
$9.99 M |
$13.45 M |
| Net Income Ratio |
-0.09 |
-0.01 |
-0.27 |
0.04 |
0.01 |
0.08 |
-0.05 |
0.05 |
0.14 |
0.22 |
| EPS |
-0.82 |
-0.11 |
-1.96 |
0.31 |
0.0829 |
0.57 |
-0.34 |
0.3 |
0.77 |
1.03 |
| EPS Diluted |
-0.82 |
-0.11 |
-1.96 |
0.3 |
0.0813 |
0.55 |
-0.34 |
0.29 |
0.76 |
1.01 |
| Weighted Average Shares
Out |
$14.15 M
|
$14.03 M
|
$13.92 M
|
$13.77 M
|
$13.55 M
|
$13.39 M
|
$13.11 M
|
$13.15 M
|
$13.00 M
|
$13.03 M
|
| Weighted Average Shares
Out Diluted |
$14.15 M
|
$14.03 M
|
$13.92 M
|
$13.99 M
|
$13.81 M
|
$13.78 M
|
$13.16 M
|
$13.39 M
|
$13.22 M
|
$13.29 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
